Differential susceptibility of retroviruses to nucleoside analogues (Q34349394)

1 August 2017

title

Differential susceptibility of retroviruses to nucleoside analogues (English)

1 reference

1 August 2017

L L Rosenblum

1 reference

1 August 2017

G Patton

1 reference

1 August 2017

A R Grigg

1 reference

1 August 2017

A J Frater

1 reference

1 August 2017

D Cain

1 reference

1 August 2017

O Erlwein

1 reference

1 August 2017

C L Hill

1 reference

1 August 2017

J R Clarke

1 reference

1 August 2017

M O McClure

1 reference

1 August 2017

publication date

1 March 2001

1 reference

Antiviral Chemistry & Chemotherapy

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

91-97

1 reference

RNA-dependent DNA polymerase in virions of RNA tumour viruses

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

A comparative study of higher primate foamy viruses, including a new virus from a gorilla

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Mink Lung Cells: A Non-primate Cell Line Highly Susceptible for Varicella-Zoster Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

The effect of zidovudine on chronic myelopathy associated with HTLV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Inhibition of the in vitro infectivity and cytopathic effect of human foamy virus by dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Long terminal repeat U3 length polymorphism of human foamy virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Pathogenesis and treatment of HTLV-I associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020101200202

10.1177/095632020101200202

21 January 2018

Identifiers

DOI

1 reference

release_nuzog5a6vbgsfl4ilnddqobrlu

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nuzog5a6vbgsfl4ilnddqobrlu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference